Detalhe da pesquisa
1.
Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults.
Mol Psychiatry;
28(3): 1248-1255, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36476732
2.
Astrocyte biomarker signatures of amyloid-ß and tau pathologies in Alzheimer's disease.
Mol Psychiatry;
27(11): 4781-4789, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35948658
3.
Replication of a predictive model for youth ADHD in an independent sample from a developing country.
J Child Psychol Psychiatry;
64(1): 167-174, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35959538
4.
The synergistic effect of genetic and environmental factors in the development of attention-deficit/hyperactivity disorder symptoms in children and adolescents.
Dev Psychopathol;
: 1-11, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37092659
5.
Association between preterm infant size at 1 year and ADHD later in life: data from 1993 and 2004 Pelotas Birth Cohorts.
Eur Child Adolesc Psychiatry;
32(9): 1589-1597, 2023 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35274169
6.
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
Alzheimers Dement;
19(10): 4463-4474, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37534889
7.
Blood-brain barrier integrity impacts the use of plasma amyloid-ß as a proxy of brain amyloid-ß pathology.
Alzheimers Dement;
19(9): 3815-3825, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36919582
8.
Attention-deficit/hyperactivity disorder has a state-dependent association with asthma: The role of systemic inflammation in a population-based birth cohort followed from childhood to adulthood.
Brain Behav Immun;
97: 239-249, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34371132
9.
Caffeine and cannabinoid receptors modulate impulsive behavior in an animal model of attentional deficit and hyperactivity disorder.
Eur J Neurosci;
49(12): 1673-1683, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30667546
10.
Activated peripheral blood mononuclear cell mediators trigger astrocyte reactivity.
Brain Behav Immun;
80: 879-888, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31176000
11.
A Review on the Role of Inflammation in Attention-Deficit/Hyperactivity Disorder.
Neuroimmunomodulation;
25(5-6): 328-333, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29874674
12.
Increased Oxidative Parameters and Decreased Cytokine Levels in an Animal Model of Attention-Deficit/Hyperactivity Disorder.
Neurochem Res;
42(11): 3084-3092, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28664398
13.
Vascular risk burden is a key player in the early progression of Alzheimer's disease.
Neurobiol Aging;
136: 88-98, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38335912
14.
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging.
Brain Commun;
6(2): fcae043, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38482373
15.
Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials.
Neurology;
101(1): 38-45, 2023 07 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36878697
16.
The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions.
J Nucl Med;
64(3): 452-459, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36396455
17.
Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review.
World Psychiatry;
22(1): 129-149, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36640395
18.
Astrocyte reactivity influences the association of amyloid-ß and tau biomarkers in preclinical Alzheimer's disease.
Res Sq;
2023 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36778243
19.
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.
JAMA Neurol;
80(2): 188-199, 2023 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36508198
20.
Astrocyte reactivity influences amyloid-ß effects on tau pathology in preclinical Alzheimer's disease.
Nat Med;
29(7): 1775-1781, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37248300